Your browser doesn't support javascript.
loading
Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between DPYD-genotype variants and P-uracil concentrations.
Paulsen, Niels Herluf; Qvortrup, Camilla; Vojdeman, Fie Juhl; Plomgaard, Peter; Andersen, Stig Ejdrup; Ramlov, Anne; Bertelsen, Birgitte; Rossing, Maria; Nielsen, Claus Gyrup; Hoffmann-Lücke, Elke; Greibe, Eva; Spangsberg Holm, Hanne; Nielsen, Heidi Hvid; Lolas, Ihab Bishara Yousef; Madsen, Jonna Skov; Bergmann, Marianne Lerbaek; Mørk, Morten; Fruekilde, Palle B Nielsen; Bøttger, Pernille; Petersen, Peter Clausager; Nissen, Peter Henrik; Feddersen, Søren; Bergmann, Troels K; Pfeiffer, Per; Damkier, Per.
Affiliation
  • Paulsen NH; Department of Clinical Pharmacology, Odense University Hospital, Odense, Denmark.
  • Qvortrup C; Clinical Pharmacology, Pharmacy and Environmental Medicine Department of Public Health, University of Southern Denmark, Odense, Denmark.
  • Vojdeman FJ; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Plomgaard P; Department of Clinical Biochemistry, Holbaek Hospital, Holbaek, Denmark.
  • Andersen SE; Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Ramlov A; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Bertelsen B; Clinical Pharmacology Unit, Zealand University Hospital, Roskilde, Denmark.
  • Rossing M; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Nielsen CG; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Hoffmann-Lücke E; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Greibe E; Center for Genomic Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Spangsberg Holm H; Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
  • Nielsen HH; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus N, Denmark.
  • Lolas IBY; Institute for Clinical Medicine, Aarhus University of Health, Aarhus, Denmark.
  • Madsen JS; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus N, Denmark.
  • Bergmann ML; Institute for Clinical Medicine, Aarhus University of Health, Aarhus, Denmark.
  • Mørk M; Department of Oncology, Odense University Hospital, Odense, Denmark.
  • Fruekilde PBN; Department of Clinical Biochemistry, Zealand University Hospital, Køge, Denmark.
  • Bøttger P; Department of Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark.
  • Petersen PC; Department of Biochemistry and Immunology, Lillebaelt Hospital - University Hospital of Southern Denmark, Vejle, Denmark.
  • Nissen PH; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
  • Feddersen S; Department of Biochemistry and Immunology, Lillebaelt Hospital - University Hospital of Southern Denmark, Vejle, Denmark.
  • Bergmann TK; Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
  • Pfeiffer P; Department of Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark.
  • Damkier P; Department of Clinical Biochemistry, Odense University Hospital, Odense, Denmark.
Acta Oncol ; 61(11): 1400-1405, 2022 11.
Article in En | MEDLINE | ID: mdl-36256873
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dihydrouracil Dehydrogenase (NADP) / Neoplasms Type of study: Prevalence_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dihydrouracil Dehydrogenase (NADP) / Neoplasms Type of study: Prevalence_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication: